GGT is reportedly highly expressed in malignant ovarian tumors, breast cancer, carcinoma of the thyroid, and lung cancer [14–16]; however, whether fluorescence imaging using gGlu-HMRG can detect human thyroid cancer remains to be elucidated. This evidence concerns the gene GGT1 and breast carcinoma.